Total planned funding: $1,464,274,052
Allocations
Countries/Regions
| Tanzania | $292,803,580 |
| Zambia | $272,919,639 |
| Nigeria | $260,126,610 |
| Mozambique | $136,762,599 |
| Zimbabwe | $75,813,620 |
| Uganda | $74,128,743 |
| Kenya | $68,780,640 |
| Rwanda | $66,277,125 |
| Haiti | $48,528,219 |
| Democratic Republic of the Congo | $41,755,548 |
| Ethiopia | $25,719,647 |
| Vietnam | $21,278,290 |
| Côte d'Ivoire | $17,398,187 |
| Ukraine | $16,579,088 |
| Eswatini | $12,633,454 |
| South Africa | $10,907,311 |
| South Sudan | $4,469,867 |
| Lesotho | $4,155,000 |
| Cameroon | $3,154,039 |
| Malawi | $3,125,439 |
| Namibia | $3,081,598 |
| Burundi | $1,628,564 |
| Central America Region | $704,500 |
| Botswana | $671,394 |
| Indonesia | $669,159 |
| Ghana | $202,192 |
Organizational Types
| Private Contractor | $1,464,274,052 |
Program Areas
| Treatment | $1,464,274,052 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $1,095,521,145 |
| HTXS: Treatment: Adult Treatment | $341,825,485 |
| PDTX: Treatment: Pediatric Treatment | $26,927,422 |
Top Partner Programs
Chemonics International:
$1,464,274,052
View countries